Enzymotec

Last updated
Enzymotec Ltd.
Type Public
NASDAQ: ENZY
Industry Food industry
Founded1999;24 years ago (1999)
Founder Dr. Sobhi Basheer
DefunctJanuary 11, 2018;5 years ago (2018-01-11)
FateAcquired by Frutarom
Headquarters,
Key people
Sobhi Basheer and Tali Sivan
ProductsFood ingredients
Dietary supplements
Medical food
Revenue$50.39 million (2015)
$6.17 million (2015)
$6.68 million (2015)
Number of employees
124 (2015)
Website www.enzymotec.com

Enzymotec was an Israeli speciality chemicals company. It was acquired by Frutarom in Jan 2018.

Contents

History

The company was founded in 1999 by Dr. Sobhi Basheer at the Naiot Venture Accelerator that markets products created from lipids from raw sources like fish and plants as food ingredients, dietary supplements, and medical food products for adults, children, and infants. [1] [2] [3] [4] As of 2013 it was the second biggest company in the global krill oil market with a 30% market share, and was emphasizing its potential for growth in the Chinese market for infant nutrition with its lipid-based InFat food ingredient. [3]

It began selling medical food products in the US through its subsidiary, Vaya Pharma, in 2011. [1] [5]

As of 2013 Enzymotec had raised $17 million and was selling products globally, and in the summer of 2013 it filed a prospectus for its initial public offering on NASDAQ, seeking to raise around $75M; [6] the IPO was held in October and raised $63M. [2]

In 2014 Enzymotec settled litigation with Canada-based Neptune Technologies & Bioressources over patents held by Neptune related to phospholipids like omega-3 oil extracted from krill oil. [7]

In 2015 shareholders filed a class action securities fraud case against Enzymotec over the IPO prospectus, claiming that the company's management had misrepresented its future profitability and the regulatory status of its products in China; most claims in the suit survived a motion to dismiss in December 2015. [8] [9]

Frutarom, which had built a minority position in the firm, announced on 29 Oct 2017 that it would acquire Enzymotec's remaining equity for approximately $168 million. [10] After the transaction completed on 11 Jan 2018, Enzymotec delisted from the NASDAQ. [11]

Related Research Articles

An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors. An IPO is typically underwritten by one or more investment banks, who also arrange for the shares to be listed on one or more stock exchanges. Through this process, colloquially known as floating, or going public, a privately held company is transformed into a public company. Initial public offerings can be used to raise new equity capital for companies, to monetize the investments of private shareholders such as company founders or private equity investors, and to enable easy trading of existing holdings or future capital raising by becoming publicly traded.

<span class="mw-page-title-main">Generic drug</span> Pharmaceutical equivalent to a brand-name product

A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active chemical substance is the same, the medical profile of generics is equivalent in performance. A generic drug has the same active pharmaceutical ingredient (API) as the original, but it may differ in some characteristics such as the manufacturing process, formulation, excipients, color, taste, and packaging.

Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.

<span class="mw-page-title-main">Freescale Semiconductor</span> Former American semiconductor company

Freescale Semiconductor, Inc. was an American semiconductor manufacturer. It was created by the divestiture of the Semiconductor Products Sector of Motorola in 2004. Freescale focused their integrated circuit products on the automotive, embedded and communications markets. It was bought by a private investor group in 2006, and subsequently merged into NXP Semiconductors in 2015.

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

Frutarom Industries Ltd. is an Israeli-based company that specializes in the production and distribution of extracts for flavor and fragrance. In 2015 it had sales of over $872 million.

<span class="mw-page-title-main">SodaStream</span> Israel-based manufacturing company

SodaStream International Ltd. is an Israel-based manufacturing company best-known as the maker of the consumer home carbonation product of the same name. The company's soda machines, in the style of soda siphons, add carbon dioxide to water from a pressurized cylinder to create carbonated water for drinking. It also sells more than 100 types of concentrated syrups and flavourings that are used in the process of making carbonated drinks. In 2018, SodaStream distributed its products to 80,000 individual retail stores across 45 countries.

<span class="mw-page-title-main">Teva Pharmaceuticals</span> Israeli pharmaceutical company

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Teva Pharmaceuticals was the largest generic drug manufacturer, when it was surpassed briefly by US-based Pfizer. Teva regained its market leader position once Pfizer spun off its generic drug division in a merger with Mylan, forming the new company Viatris at the end of 2020. Overall, Teva is the 18th largest pharmaceutical company in the world.

<span class="mw-page-title-main">Proxim Wireless</span>

Proxim Wireless Corporation is a San Jose, California-based company that builds scalable broadband wireless networking systems for communities, enterprises, governments, and service providers. It offers wireless LAN, point-to-multipoint and point-to-point products through a channel network. The company is a product of many mergers and acquisitions over the years.

TerraVia Holdings, Inc. was a publicly held biotechnology company in the United States. TerraVia used proprietary technology to transform a range of low-cost plant-based sugars into high-value oils and whole algae ingredients. TerraVia supplied a variety of sustainable algae-based food ingredients to a number of brands, which included Hormel Food Corporation, Utz Quality Foods Inc and enjoy Life Foods. TerraVia also sold its own culinary algae oil under the Thrive Algae Oil brand.

<span class="mw-page-title-main">Verisk Analytics</span> American data analytics and risk assessment firm

Verisk Analytics, Inc. is an American multinational data analytics and risk assessment firm based in Jersey City, New Jersey, with customers in insurance, natural resources, financial services, government, and risk management sectors. The company uses proprietary data sets and industry expertise to provide predictive analytics and decision support consultations in areas including fraud prevention, actuarial science, insurance coverage, fire protection, catastrophe and weather risk, and data management.

<span class="mw-page-title-main">Nasdaq Private Market</span> Secondary market trading venue

Nasdaq Private Market (NPM) provides a secondary market trading venue for issuers, brokers, shareholders, and prospective investors of private company stock. Since inception, NPM has facilitated more than $40 billion in transactional volume and has worked with 400+ private companies and 100,000+ employees, stakeholders, and investors. NPM offers private company and investors different solutions including tender offers, auctions, block trades, and custom company marketplaces. In 2021, NPM spun-off of Nasdaq to become its own, independent company receiving strategic investments from Silicon Valley Bank, Citi, Goldman Sachs, Morgan Stanley, and Allen and Co.

E-commerce China Dangdang Inc., known as Dangdang, is a Chinese electronic commerce company, founded by Peggy Yu and Li Guoqing in 1999. It is headquartered in Beijing and its main competitors are Amazon.cn and JD.com. The competition escalated into a price war in December 2010, with each retailer marking down a wide range of items, especially books. DangDang made an IPO on the NYSE in November 2010, estimated at approximately US$1 billion.

The technology company Facebook, Inc. held its initial public offering (IPO) on Friday, May 18, 2012. The IPO was one of the biggest in technology and Internet history, with a peak market capitalization of over $104 billion.

Two River Group Holdings is a New York-based venture capital firm and merchant bank focused on the life science sector. It specializes in investments in life science, biotechnology, and in firms focused on developing preventive and therapeutic technologies for a broad spectrum of disease areas including oncology, cardiovascular disease, neurological disorders, and companion animal health care.

Taro Pharmaceutical Industries is an Israeli research-based pharmaceutical manufacturer publicly listed in the New York Stock Exchange. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. The company's products are mainly sold in the United States, Canada and Israel. The symbol of the company in NYSE is "TARO". Taro Pharmaceutical Industries is reported to be on steady growth since 2008.

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

Neptune Wellness Solutions, Inc. is a diversified wellness company that provides nutraceuticals, organic food and beverages, and consumer packaged goods to retail and business customers. Originally known for Antarctic krill oil production, the company previously operated an industrial-scale licensed cannabis processing plant in Quebec, CA, and a hemp processing facility in North Carolina in the U.S. until selling the cannabis business in 2022.

References

  1. 1 2 "Form F-1 Registration Statement Under The Securities Act of 1933". Enzymotec via SEC Edgar. July 10, 2013. Index to whole prospectus is here
  2. 1 2 "Enzymotec raises $63.5m in Nasdaq IPO". Israel High-Tech & Investment Report. October 2013.
  3. 1 2 Dionisio, Rommel; Frederick, Kurt (October 22, 2013). "Enzymotec's Formula to Success". Barron's.
  4. "ENZY:NASDAQ GS Stock Quote - Enzymotec Ltd". Bloomberg. Retrieved 20 September 2016.
  5. "VAYA Pharma Inc.: Private Company Information". Bloomberg. Retrieved 20 September 2016.
  6. Weinreb, Gali (August 25, 2013). "Enzymotec publishes Nasdaq IPO prospectus". Jewish Business News.
  7. Daniells, Stephan (April 28, 2014). "Neptune and Enzymotec finalize patent settlement and license agreement". Nutra Ingredients.
  8. Posses, Shayna (December 15, 2015). "Enzymotec Can't Shake Shareholder Suit Over $70M IPO -". Law360.
  9. "Case Page: Enzymotec Ltd. Securities Litigation". Securities Class Action Clearinghouse. Retrieved 20 September 2016.
  10. "Israeli flavor firm Frutarom to buy remaining 81 pct of Enzymotec". October 29, 2017.
  11. "Frutarom takes full ownership of Enzymotec, sells krill oil business to Aker BioMarine". January 19, 2018. Archived from the original on 2018-01-21.